Overview

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam